- Home
- ELMD vs VNDA Comparison
ELMD vs VNDA Comparison
Compare ELMD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- VNDA
- Stock Information
- Founded
- ELMD 1992
- VNDA 2002
- Country
- ELMD United States
- VNDA United States
- Employees
- ELMD N/A
- VNDA N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- VNDA Health Care
- Exchange
- ELMD Nasdaq
- VNDA Nasdaq
- Market Cap
- ELMD 229.6M
- VNDA 237.9M
- IPO Year
- ELMD 2010
- VNDA 2006
- Fundamental
- Price
- ELMD $22.20
- VNDA $3.95
- Analyst Decision
- ELMD Strong Buy
- VNDA Strong Buy
- Analyst Count
- ELMD 1
- VNDA 2
- Target Price
- ELMD $38.00
- VNDA $16.50
- AVG Volume (30 Days)
- ELMD 44.4K
- VNDA 471.1K
- Earning Date
- ELMD 05-13-2025
- VNDA 05-07-2025
- Dividend Yield
- ELMD N/A
- VNDA N/A
- EPS Growth
- ELMD 66.51
- VNDA N/A
- EPS
- ELMD 0.75
- VNDA N/A
- Revenue
- ELMD $59,626,000.00
- VNDA $201,351,000.00
- Revenue This Year
- ELMD $17.91
- VNDA $14.36
- Revenue Next Year
- ELMD $11.70
- VNDA $44.53
- P/E Ratio
- ELMD $29.90
- VNDA N/A
- Revenue Growth
- ELMD 15.35
- VNDA 13.37
- 52 Week Low
- ELMD $13.74
- VNDA $3.85
- 52 Week High
- ELMD $35.56
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- ELMD 39.10
- VNDA 33.16
- Support Level
- ELMD $21.81
- VNDA $4.20
- Resistance Level
- ELMD $23.50
- VNDA $4.51
- Average True Range (ATR)
- ELMD 0.72
- VNDA 0.18
- MACD
- ELMD 0.03
- VNDA -0.02
- Stochastic Oscillator
- ELMD 20.59
- VNDA 1.43
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.